About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Postmenopausal Osteoporosis: Clinical Guide on Selective Estrogen Receptor Modulators

by Kathy Jones on March 2, 2012 at 8:55 PM
Font : A-A+

 Postmenopausal Osteoporosis: Clinical Guide on Selective Estrogen Receptor Modulators

The publication of an important clinical guide from the European Menopause and Andropause Society (EMAS) in the February issue of Maturitas has been announced by Elsevier, a world-leading provider of scientific, technical and medical information products and services.

This clinical guide details the role of selective estrogen receptor modulators (SERMs) against postmenopausal osteoporosis as the European Medicines Agency (EMA) has approved the use of bazedoxifene and lasofoxifene.

Advertisement

Postmenopausal osteoporosis and resulting fractures have a major impact on morbidity and mortality and are major public health issues. Various therapies such as bisphosphonates, strontium ranelate and more recently denomsumab are available but these are not suitable for all women. Health concerns have been raised resulting from these therapies, such as oesophageal cancer, osteonecrosis of the jaw (ONJ) and subtrochanteric fractures with bisphosphonates and venous thromboembolism with strontiumranelate. Use of bazedoxifene and lasofoxifene will increase the number of therapeutic options available as these new SERMs point to a greater anti-fracture potential.

The decision of which type of treatment to use for osteoporosis and when to begin should be based on the need to reduce fracture risk. All treatments including SERMs should include recommendations for a healthy life style and adequate calcium and vitamin D intake. Additional benefits of different agents (i.e. climacteric symptom improvement with estrogens, breast cancer prevention for SERMS) must be considered when selecting the anti-osteoporosis drug. Furthermore what agent is used (estrogen, SERM, bisphosphonates) may vary over a woman's life time. The clinical guide from the European Menopause and Andropause Society (EMAS) details all important and necessary aspects of consideration.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Menopause Dilatation and Curettage Oophorectomy Hormone Replacement Therapy Dealing with Menopause symptoms through lifestyle changes Estrogen Dominance Hormonal Imbalance Perimenopause High Testosterone Level In Women / Hyperandrogenism 

Most Popular on Medindia

Loram (2 mg) (Lorazepam) Calculate Ideal Weight for Infants Find a Doctor Nutam (400mg) (Piracetam) How to Reduce School Bag Weight - Simple Tips Post-Nasal Drip Daily Calorie Requirements Diaphragmatic Hernia Blood Pressure Calculator Iron Intake Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Postmenopausal Osteoporosis: Clinical Guide on Selective Estrogen Receptor Modulators Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests